Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$10,600,000
Lobbying expense
—
Federal awards
—
Relationships
151
| Inc. Cellphire |
| $200,000 |
| — |
| lobbied by | Shionogi Inc. | $180,000 | — |
| lobbied by | Tonix Pharmaceuticals Holding Corp. | $160,000 | — |
| lobbied by | Inc. Cellphire | $160,000 | — |
| lobbied by | Inc. Cellphire | $160,000 | — |
| lobbied by | Inc. Cellphire | $160,000 | — |
| lobbied by | Pacific Technologies And Solutions | $160,000 | — |
| lobbied by | Tonix Pharmaceuticals Holding Corp. | $160,000 | — |
| lobbied by | Apco Worldwide Llc (on Behalf Of Quidelortho) | $160,000 | — |
| lobbied by | Inc. Cellphire | $160,000 | — |
| lobbied by | Gradient Technology | $150,000 | — |
| lobbied by | Inc. Cellphire | $150,000 | — |
| lobbied by | Avalo Therapeutics | $150,000 | — |
| lobbied by | Gradient Technology | $150,000 | — |
| lobbied by | Pacific Technologies And Solutions | $130,000 | — |
| lobbied by | Shionogi Inc. | $130,000 | — |
| lobbied by | Gradient Technology | $120,000 | — |
| lobbied by | Inc. Cellphire | $120,000 | — |
| lobbied by | Gradient Technology | $120,000 | — |
| lobbied by | Gradient Technology | $120,000 | — |
| lobbied by | Ervin Graves Strategy On Behalf Of Greffex Inc. | $120,000 | — |
| lobbied by | Ervin Graves Strategy Llc On Behalf Of Byheart Inc | $100,000 | — |
| lobbied by | Ltd. Amo Pharma | $100,000 | Apr 17, 2026 – Jul 19, 2026 |
| lobbied by | Apco Worldwide Llc (on Behalf Of Quidelortho) | $100,000 | — |
| lobbied by | Gradient Technology | $100,000 | Apr 17, 2026 – Jul 19, 2026 |
| lobbied by | Ervin Graves Strategy Llc On Behalf Of Byheart Inc | $100,000 | — |
| lobbied by | Apco Worldwide Llc (on Behalf Of Quidelortho) | $90,000 | Apr 17, 2026 – Jul 19, 2026 |
| lobbied by | Inc. Cellphire | $90,000 | — |
| lobbied by | Shionogi Inc. | $90,000 | — |
| lobbied by | Ervin Graves Strategy On Behalf Of Greffex Inc. | $90,000 | — |
| lobbied by | Emergent Biosolutions Inc (f/k/a Adapt Pharma Inc ) | $90,000 | — |
| lobbied by | Acer Therapeutics | $80,000 | — |
| lobbied by | Ervin Graves Strategy Llc On Behalf Of Byheart Inc | $80,000 | — |
| lobbied by | Acer Therapeutics | $80,000 | — |
| lobbied by | Ervin Graves Strategy Llc On Behalf Of Byheart Inc | $80,000 | — |
| lobbied by | Tonix Pharmaceuticals Holding Corp. | $80,000 | Apr 17, 2026 – Jul 19, 2026 |
| lobbied by | Acer Therapeutics | $80,000 | — |
| lobbied by | Shionogi Inc. | $80,000 | Apr 17, 2026 – Jul 19, 2026 |
| lobbied by | Gradient Technology | $80,000 | — |
| lobbied by | Goldbelt Inc. | $80,000 | — |
| lobbied by | Ervin Graves Strategy Llc On Behalf Of Byheart Inc | $80,000 | — |
| lobbied by | Inc. Signature Performance | $80,000 | — |
| lobbied by | Inc The Conafay Group Llc O/b/o Realta Life Sciences | $80,000 | — |
| lobbied by | Ervin Graves Strategy On Behalf Of Lyndra Therapeutics Fka Ervin Hill Strategy | $80,000 | — |
| lobbied by | Goldbelt Inc. | $80,000 | — |
| lobbied by | Avalo Therapeutics | $80,000 | — |
| lobbied by | Pacific Technologies And Solutions | $80,000 | — |